The class of compounds known as p105 inhibitors comprises a diverse group of molecules that primarily target the nuclear factor kappa B (NF-κB) pathway, specifically focusing on the precursor protein p105, which is an integral component of the NF-κB signaling cascade. The NF-κB pathway plays a pivotal role in regulating various cellular processes, including immune response, inflammation, and cell survival. Central to this pathway is the p105 protein, a precursor of the p50 subunit of NF-κB. The p105 inhibitor class includes a range of chemical entities with distinct structures and modes of action, all aimed at modulating the NF-κB pathway by influencing p105 processing and the subsequent activation of NF-κB.
These inhibitors exert their effects by interfering with critical steps in the NF-κB activation process. One common mechanism involves the blockade of IκB kinase (IKK) activity, preventing the phosphorylation and degradation of IκBα, which is a key regulatory protein that sequesters NF-κB in the cytoplasm. By inhibiting IKK activity, p105 inhibitors indirectly hamper the proteasomal degradation of IκBα, thereby halting the release of active NF-κB subunits. Moreover, certain p105 inhibitors target the proteolytic processing of p105 itself. In the canonical NF-κB pathway, p105 serves as a precursor to the p50 subunit. These inhibitors impede the processing of p105 into p50 by inhibiting enzymes responsible for this cleavage, effectively curtailing the availability of active NF-κB subunits. As a result, the cellular response to various stimuli that trigger NF-κB activation is diminished. The complexity and diversity of the p105 inhibitor class reflect the intricate regulatory network of the NF-κB pathway. These compounds offer valuable tools for researchers studying cellular signaling and inflammation, aiding in the deciphering of NF-κB-mediated processes. Through their influence on p105 processing and NF-κB activation, p105 inhibitors contribute to our understanding of fundamental biological pathways and hold the ability to uncovering new insights into cellular behavior beyond their explored applications.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB activation by blocking IκBα phosphorylation. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
Selectively inhibits p105 processing, preventing NF-κB activation. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $133.00 | 12 | |
Blocks p105 processing and nuclear translocation of NF-κB. | ||||||
IMD 0354 | 978-62-1 | sc-203084 | 5 mg | $199.00 | 3 | |
Inhibits the translocation of p50 subunit, suppressing NF-κB. | ||||||
ML 120B Dihydrochloride | 783348-36-7 (free base) | sc-487759 | 5 mg | $380.00 | ||
Targets TAK1 kinase, disrupting the activation of p105 processing. | ||||||
SC514 | 354812-17-2 | sc-205504 sc-205504A | 5 mg 10 mg | $67.00 $91.00 | 13 | |
Suppresses IκBα kinase activity, preventing p105 degradation. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $312.00 | 1 | |
Selectively inhibits IKKβ, leading to p105 stabilization. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Reduces p105 phosphorylation and impedes NF-κB activation. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Blocks IκBα phosphorylation, preventing p105 degradation. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Modulates NF-κB pathway, affecting p105 processing and stability. | ||||||